Harada's disease digital illustration

Harada's disease Save


ICD-10 code: H30.81

Chapter: Diseases of the eye and adnexia

What is Harada's Disease?
Harada's disease, also known as Vogt-Koyanagi-Harada (VKH) disease, is a rare autoimmune disorder that affects various organs in the body, including the eyes, ears, skin, and meninges.

Harada's disease is more prevalent in certain ethnic groups, particularly those with Asian, Middle Eastern, Native American, and Hispanic backgrounds. The condition can affect individuals of any age, but it is more common in young adults between the ages of 20 and 50 years old.

Symptoms of Harada's Disease
The symptoms of Harada's disease vary depending on which organs are affected. The most common symptoms include:
  1. Blurred vision or vision loss
  2. Eye pain or redness
  3. Sensitivity to light
  4. Tinnitus or hearing loss
  5. Headache
  6. Nausea and vomiting
  7. Skin rash
  8. Hair loss

Harada's disease can also cause neurological symptoms, such as meningitis, which can lead to confusion, seizures, and difficulty with balance and coordination.

Treatment for Harada's Disease
There is no cure for Harada's disease, but early treatment can help manage symptoms and prevent complications. Treatment typically involves the use of anti-inflammatory medications, such as corticosteroids, to reduce inflammation in the affected organs.

In some cases, immunosuppressant medications may also be used to suppress the immune system and prevent further damage to the affected organs. Treatment for Harada's disease is usually long-term, and patients require regular follow-up appointments with their healthcare provider to monitor their condition.

Conclusion
Harada's disease is a rare autoimmune disorder that affects multiple organs in the body, including the eyes, ears, skin, and meninges. Early diagnosis and treatment are essential in managing symptoms and preventing complications. If you suspect you or a loved one may have Harada's disease, it's essential to seek medical attention promptly.